a gbp 130 derived peptide from plasmodium falciparum binds to human erythrocytes and inhibits merozoite invasion in vitro

Clicks: 253
ID: 144332
2000
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #119 of 450 articles by views in kurdistan journal of applied research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 450 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The malarial GBP 130 protein binds weakly to intact human erythrocytes; the binding sites seem to be located in the repeat region and this region's antibodies block the merozoite invasion. A peptide from this region (residues from 701 to 720) which binds to human erythrocytes was identified. This peptide named 2220 did not bind to sialic acid; the binding site on human erythrocyte was affected by treatment with trypsin but not by chymotrypsin. The peptide was able to inhibit Plasmodium falciparum merozoite invasion of erythrocytes. The residues F701, K703, L705, T706, E713 (FYKILTNTDPNDEVERDNAD) were found to be critical for peptide binding to erythrocytes.
Reference Key
suarez2000memriasa Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Jorge E Suarez;Mauricio Urquiza;Hernando Curtidor;Luis E Rodriguez;Marisol Ocampo;Elizabeth Torres;Fanny Guzman;Manuel Elkin Patarroyo
Journal kurdistan journal of applied research
Year 2000
DOI
10.1590/S0074-02762000000400009
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.